Linerixibat
CAS: 1345982-69-5
Ref. 3D-VDC98269
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire |
Product Information
Linerixibat is a drug that has been shown to reduce the accumulation of fat in the liver by inhibiting the synthesis and secretion of bile acids. Linerixibat also inhibits glucose transport, leading to a reduction in plasma glucose levels. It is also used as a pharmacological agent for the treatment of cholestatic liver diseases. In vitro assays have been performed on human hepatocytes to investigate Linerixibat's biological properties and its effects on multidrug resistance-associated protein (MRP2). These assays show that Linerixibat increases MRP2 expression, which leads to increased serum levels of drugs such as cyclosporin A.
Chemical properties
Technical inquiry about: 3D-VDC98269 Linerixibat
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
